close
Share with your friends

Deal Capsule - October 2019

Deal Capsule - October 2019

M&A activity will remain moderately strong in both sectors.

1000

Ansprechpartner

Christian Klingbeil

Partner, Deal Advisory - Valuation

KPMG AG Wirtschaftsprüfungsgesellschaft

Contact

Related content

Reagenzgläser

Topic of this issue:

While Q3 2019 M&A activity remains short of prior year in Life Sciences and Chemicals, large deals continue to dominate the M&A landscape. Life Sciences` deal value continues to outpace prior year including blockbuster deals, portfolio reorganization, oncology and medical cannabis deals. M&A within Chemicals shows a similar picture, yet at a lower level, primarily driven by structural changes in China and large acquisitions in the US.

Online version

Browse directly through the publication

KPMG Deal Capsule Newsletter

© 2019 KPMG AG Wirtschaftsprüfungsgesellschaft, ein Mitglied des KPMG-Netzwerks unabhängiger Mitgliedsfirmen, die KPMG International Cooperative (“KPMG International”), einer juristischen Person schweizerischen Rechts, angeschlossen sind. Alle Rechte vorbehalten.

Connect with us

 

Want to do business with KPMG?

 

loading image Request for proposal